The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Clinical trial NCT03369301 · COMPLETED

Trial details

NCT number: NCT03369301
Sponsor: Octapharma
Status: COMPLETED
Study type: OBSERVATIONAL

Secondary Immune Deficiency

Start date: 2017-09-25
Primary completion: 2019-11-22
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.